IS6224A - Aðferð til kristöllunar N- (1(S)-etoxýkarbonýl-3-fenýlprópýl)-L-alanín-N-karboxýlanhýdríðs - Google Patents
Aðferð til kristöllunar N- (1(S)-etoxýkarbonýl-3-fenýlprópýl)-L-alanín-N-karboxýlanhýdríðsInfo
- Publication number
- IS6224A IS6224A IS6224A IS6224A IS6224A IS 6224 A IS6224 A IS 6224A IS 6224 A IS6224 A IS 6224A IS 6224 A IS6224 A IS 6224A IS 6224 A IS6224 A IS 6224A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylpropyl
- ethoxycarbonyl
- alanine
- carboxylanhydride
- crystallizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000141717 | 2000-05-15 | ||
| JP2000330339 | 2000-10-30 | ||
| JP2000352892 | 2000-11-20 | ||
| PCT/JP2001/004059 WO2001087858A1 (fr) | 2000-05-15 | 2001-05-15 | Procedes de cristallisation d'un n-carboxyanhydride de n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6224A true IS6224A (is) | 2002-01-09 |
Family
ID=27343377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6224A IS6224A (is) | 2000-05-15 | 2002-01-09 | Aðferð til kristöllunar N- (1(S)-etoxýkarbonýl-3-fenýlprópýl)-L-alanín-N-karboxýlanhýdríðs |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6784310B2 (is) |
| EP (1) | EP1283204B1 (is) |
| JP (1) | JP4149706B2 (is) |
| KR (1) | KR100527648B1 (is) |
| CN (1) | CN1184213C (is) |
| AT (1) | ATE423106T1 (is) |
| AU (1) | AU5675801A (is) |
| CZ (1) | CZ2002532A3 (is) |
| DE (1) | DE60137686D1 (is) |
| ES (1) | ES2320413T3 (is) |
| HR (1) | HRP20020122A2 (is) |
| HU (1) | HUP0202516A3 (is) |
| IS (1) | IS6224A (is) |
| PL (1) | PL351841A1 (is) |
| SI (1) | SI20817A (is) |
| TW (1) | TW527351B (is) |
| WO (1) | WO2001087858A1 (is) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7683101B2 (en) | 2003-08-29 | 2010-03-23 | Sekisui Plastics Co., Ltd. | Pre-expanded particle of olefin-modified polystyrene resin, process for producing the same, and molded foam |
| JP4852282B2 (ja) * | 2005-08-29 | 2012-01-11 | 保土谷化学工業株式会社 | Ｎ−カルボン酸無水物の製造方法 |
| CN101293887A (zh) * | 2007-04-26 | 2008-10-29 | 中国科学院福建物质结构研究所 | 一种高纯度环状硫酸酯的纯化方法 |
| JP2011016790A (ja) | 2009-06-08 | 2011-01-27 | Sumitomo Chemical Co Ltd | ピラゾリノン誘導体の精製方法 |
| WO2014202659A1 (en) | 2013-06-21 | 2014-12-24 | Sanofi-Aventis Deutschland Gmbh | Process for the preparation of amides of n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine |
| EP3810579B2 (en) | 2018-09-28 | 2024-04-17 | Lonza Ltd. | Method for preparation of n-carboxyanhydrides |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4831184A (en) * | 1981-03-30 | 1989-05-16 | Rorer Pharmaceutical Corporation | N-substituted-amido-amino acids |
| US4496542A (en) * | 1981-03-30 | 1985-01-29 | Usv Pharmaceutical Corporation | N-substituted-amido-amino acids |
| JPS6248696A (ja) * | 1985-08-27 | 1987-03-03 | Kanegafuchi Chem Ind Co Ltd | Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法 |
| SI9200213A (en) * | 1992-09-16 | 1994-03-31 | Krka | Process for preparing alkyl-l-alanil-l-proline derivates |
| HU215699B (hu) | 1992-11-13 | 1999-02-01 | E. I. Du Pont De Nemours And Co. | Eljárás 2,4-oxazolidin-dionok és intermedierjeik előállítására |
| IN184759B (is) * | 1997-07-22 | 2000-09-23 | Kaneka Corp | |
| JP4505917B2 (ja) | 1999-01-22 | 2010-07-21 | 田辺三菱製薬株式会社 | 新規微生物およびそれを用いるｌ−アミノ酸の製法 |
-
2001
- 2001-05-15 AU AU56758/01A patent/AU5675801A/en not_active Abandoned
- 2001-05-15 DE DE60137686T patent/DE60137686D1/de not_active Expired - Lifetime
- 2001-05-15 AT AT01930174T patent/ATE423106T1/de active
- 2001-05-15 CZ CZ2002532A patent/CZ2002532A3/cs unknown
- 2001-05-15 SI SI200120002A patent/SI20817A/sl not_active IP Right Cessation
- 2001-05-15 HU HU0202516A patent/HUP0202516A3/hu unknown
- 2001-05-15 PL PL01351841A patent/PL351841A1/xx not_active IP Right Cessation
- 2001-05-15 JP JP2001584254A patent/JP4149706B2/ja not_active Expired - Fee Related
- 2001-05-15 KR KR10-2002-7000541A patent/KR100527648B1/ko active IP Right Grant
- 2001-05-15 ES ES01930174T patent/ES2320413T3/es not_active Expired - Lifetime
- 2001-05-15 US US10/019,318 patent/US6784310B2/en not_active Expired - Fee Related
- 2001-05-15 CN CNB018012582A patent/CN1184213C/zh not_active Expired - Lifetime
- 2001-05-15 TW TW090111623A patent/TW527351B/zh not_active IP Right Cessation
- 2001-05-15 EP EP01930174A patent/EP1283204B1/en not_active Expired - Lifetime
- 2001-05-15 WO PCT/JP2001/004059 patent/WO2001087858A1/ja active IP Right Grant
-
2002
- 2002-01-09 IS IS6224A patent/IS6224A/is unknown
- 2002-02-11 HR HR20020122A patent/HRP20020122A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6784310B2 (en) | 2004-08-31 |
| WO2001087858A1 (fr) | 2001-11-22 |
| ATE423106T1 (de) | 2009-03-15 |
| HUP0202516A2 (hu) | 2003-01-28 |
| CN1184213C (zh) | 2005-01-12 |
| DE60137686D1 (de) | 2009-04-02 |
| CZ2002532A3 (cs) | 2002-05-15 |
| KR100527648B1 (ko) | 2005-11-09 |
| HUP0202516A3 (en) | 2003-04-28 |
| PL351841A1 (en) | 2003-06-16 |
| SI20817A (sl) | 2002-08-31 |
| EP1283204B1 (en) | 2009-02-18 |
| EP1283204A1 (en) | 2003-02-12 |
| JP4149706B2 (ja) | 2008-09-17 |
| EP1283204A4 (en) | 2007-09-05 |
| TW527351B (en) | 2003-04-11 |
| HRP20020122A2 (en) | 2003-04-30 |
| CN1380881A (zh) | 2002-11-20 |
| AU5675801A (en) | 2001-11-26 |
| KR20020038689A (ko) | 2002-05-23 |
| ES2320413T3 (es) | 2009-05-22 |
| US20020137944A1 (en) | 2002-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV10575A (lv) | Izoksazoi-4-karbonskabes amids un hidroksialkiliden-cianetikskabes amids sos savienojumus saturosi astniecibas lidzekli un to pielietojums | |
| DE69623444D1 (de) | Substituierte isoxazole zur behandlung von entzündung | |
| AU2001264679A1 (en) | Synthesis of n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methylester using oxazolidinone derivatives | |
| DE69512797T2 (de) | Prostaglandin-synthase hemmer | |
| HUP9802488A2 (hu) | Eljárás Kathepszin K gátlására | |
| BR0015836A (pt) | Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp | |
| IS6224A (is) | Aðferð til kristöllunar N- (1(S)-etoxýkarbonýl-3-fenýlprópýl)-L-alanín-N-karboxýlanhýdríðs | |
| AR048279A1 (es) | La forma ii cristalina de cabergolina | |
| ES2178214T3 (es) | Preparacion de zeolita l. | |
| EP1468997A3 (en) | Polymorphous forms of rosiglitazone maleate | |
| RU96115027A (ru) | Новая протеаза | |
| DE50207212D1 (de) | Verfahren zur herstellung von 2-pyrrolidon | |
| CA2414936A1 (en) | Thiophene retinoids | |
| HUP0004932A2 (hu) | Eljárás egy édesítőszer elkülönítésére vagy tisztítására | |
| Isowa et al. | Acylation of N δ-Benzyloxyornithine | |
| DE60019723D1 (de) | Eine methode zur herstellung von verbindungen der formel 1 und derivaten | |
| JPS5225768A (en) | Preparation of novel pentapeptides | |
| AR011188A1 (es) | Proceso para la produccion de acido maleico a partir de anhidrido maleico y agua | |
| BR9914826A (pt) | Processo de cristalização de cristais de éster metìlico de n- [n-(3,3-dimetilbutil)-l-alfa-aspartil] -l-fenilalanina | |
| HUP0004149A2 (hu) | Eljárás N-[1(S)-etoxi-karbonil-3-fenil-propil]-L-alanil-L-prolin maleát só kristályosítására | |
| JPS5419966A (en) | Production of pyroglutamine peptide | |
| ATE282046T1 (de) | Herstellung von n-(n-(3,3-dimethylbutyl)-l-alpha- aspartlyl)-l-phenylalaninmethylester mittels reduktiver alkylation und crystallisierung im wässrigen methanol | |
| BR9813595A (pt) | Cristal misto, processo para produzir o mesmo, e, adoçante | |
| KR940000575A (ko) | 프로테아제 및 그 이용방법 | |
| MXPA02010182A (es) | Metodos de uso de penicilaminas para el tratamiento de condiciones que resultan del dano en el adn. |